Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Japanese scientists develop potent, orally active antihypertensive agent

March 31, 1998

New peripheral vasodilator from Otsuka profiled at recent meeting

March 31, 1998

Quinoline derivative from Green Cross/Asahi Glass shows promising antihypertensive efficacy

March 31, 1998

Antiarrhythmic Na+/H+ exchange inhibitors prepared by Hoechst

March 31, 1998

ACE inhibitors outshine Ca2+ channel blockers for preventing cardiovascular events in diabetics

March 31, 1998

Phase I study results reported for TP10 in AMI

March 31, 1998

Pharmacological profile of new PDE V inhibitor from Eisai

March 31, 1998

KRH-594 evaluated in animal models of nephropathy, vascular hyperplasia

March 30, 1998

Adenosine derivatives for cardiovascular, lipid disorders

March 30, 1998

Lilly evaluates cardiovascular effects of Evista in RUTH trial

March 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...